Next Article in Journal
Endogenous Neurostimulation and Physiotherapy in Cluster Headache: A Clinical Case
Next Article in Special Issue
Molecular Biomarkers in Fragile X Syndrome
Previous Article in Journal
Reasoning on Figurative Language: A Preliminary Study on Children with Autism Spectrum Disorder and Klinefelter Syndrome
Previous Article in Special Issue
Repeat Instability in the Fragile X-Related Disorders: Lessons from a Mouse Model
Review

Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells

Centre for Brain Development and Repair, Institute for Stem Cell Biology and Regenerative Medicine, GKVK Post, Bellary Road, Bengaluru 560065, India
*
Author to whom correspondence should be addressed.
Brain Sci. 2019, 9(3), 59; https://doi.org/10.3390/brainsci9030059
Received: 3 December 2018 / Revised: 27 February 2019 / Accepted: 6 March 2019 / Published: 11 March 2019
(This article belongs to the Special Issue Towards Mechanism-based Treatments for Fragile X Syndrome)
The most conserved molecular phenotype of Fragile X Syndrome (FXS) is aberrant protein synthesis. This has been validated in a variety of experimental model systems from zebrafish to rats, patient-derived lymphoblasts and fibroblasts. With the advent of personalized medicine paradigms, patient-derived cells and their derivatives are gaining more translational importance, not only to model disease in a dish, but also for biomarker discovery. Here we review past and current practices of measuring protein synthesis in FXS, studies in patient derived cells and the inherent challenges in measuring protein synthesis in them to offer usable avenues of modeling this important metabolic metric for further biomarker development. View Full-Text
Keywords: protein synthesis; Fragile X Syndrome; biomarker; iPSC; fibroblast; lymphoblast protein synthesis; Fragile X Syndrome; biomarker; iPSC; fibroblast; lymphoblast
Show Figures

Figure 1

MDPI and ACS Style

Pal, R.; Bhattacharya, A. Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells. Brain Sci. 2019, 9, 59. https://doi.org/10.3390/brainsci9030059

AMA Style

Pal R, Bhattacharya A. Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells. Brain Sciences. 2019; 9(3):59. https://doi.org/10.3390/brainsci9030059

Chicago/Turabian Style

Pal, Rakhi, and Aditi Bhattacharya. 2019. "Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells" Brain Sciences 9, no. 3: 59. https://doi.org/10.3390/brainsci9030059

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop